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Time Evolutive (Recursive) Heart Rate Variability
Analysis Provides New Insights into the Mechanisms
of Vasovagal Syncope During Head-up Tilt Test
Etienne Pruvot, Karin Vibe 1, Jean M. Vesin 1, Jurg Schlapfer, Martin Fromer,
Lukas Kappenberger. C.H. U V. Laussane, Switzerland; 1Polytechnical School.
Lausanne, Switzerland
Vasovagal syncope (W5) during head-up tilt test (HUT) is the result of an im-
balance of the sympathovagal tone (5t). However, standard heart rate vari-
ability analysis (HRV) is of limited value in understanding W5 mechanisms
as it gives no insight into beat to beat modulation (88M) of the 5t and re-
quires stationary conditions. We used a new method based on a recursive
estimation of HRV temporal indices to compare 88M of the vagal tone in 10
patients (pts) (27 ± 8) with W5 during positive HUT to 10 control subjects
(C) (32 ± 3) during 30 min. negative HUT.
Results:
Patients with VVS
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Conclusions: Time evolutive HRV demonstrates, in the last seconds be-
fore syncope, the paradoxical vagal input to the sinus node confirmed by a
sudden raise of sinus variability, never shown before. Time evolutive HRV
is a promising method yielding new insights into the imbalance of the 5t
appearing during VVS.
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1749-41 Role of Autonomic Tone in the Induction of Coronary
Spasm in Patients with Variant Angina with or without
Obstructive Coronary Stenoses
Gaetano A. Lanza, Patrizia Pedrotti, Elena Bia, V,ncenzo Pascen, Michele Lucenle,
Filippo Crea, Attilio Maseri. Istituto di Cardiologia, UniversitiJ Cattolica del S. Cuore,
Roma,/taly
To evaluate the role of autonomic tone in the induction of coronary spasm,
we analysed time- and frequency-domain indexes of heart rate variability
(HRV) preceding episodes of 5T elevation (5Te) detected on Holter moni-
toring in 23 patients (17 men, age 59 ± 12 yrs) with variant angina. Only
5Te episodes lasting :::3 minutes and with no 5T changes in the previous 40
min. were selected for the analysis. Of a total of 239 5Te episodes, 93139%,
3.5 ± 3 episodeslpt, range 1-12) fulfilled the inclusion criteria. HRV indexes
were calculated on 2-minute intervals, centered at 3D, 15, 5 and 1 minutes
before 5Te. The HRV changes were compared in 50 episodes of 10 pts with
no significant stenosis (Group 1) and in 43 episodes of 13 pts with significant
stenoses (>50%) at coronary angiography. HRV indexes showed no change
from 30 to 15 and 5 minutes before 5Te in both groups. At 1 minute before
5Te, HRV analysis showed relevant changes in several specific indexes of va-
gal activity in group 1, while a significant reduction was observed onlyfor HF
in group 2. HRV values observed 30' and l' before (8) 5Te are summarized
in the table.
Group 1 Group 2
30'B STe l'B STe 30'B STe l'B STe
RR (msec) 957±168 937 ± 171 842 ± 196 826 ± 175
r-MSSD (msec) 334 ± 23 26.4 ± 18' 28.0 ± 14 29.4 ± 14
pNN50(%) 99 ± 14 7.6 ± 13' 10.8 ± 12 10.2 ± 10
LF (msec2) 396 ± 225 256 ± 49 734 ± 484 566 ± 256
HF (msec2) 292 ± 144 178 ± 81' 269 ± 81 185 ± 36'
'p < 0.01: 'p < 0.05
Thus, our data show that a reduction in vagal activity precedes ischemic
episodes in patients with variant angina, suggesting that it may facilitate the
induction of coronary spasm. The degree of vagal withdrawal, however, is
much higher in pts with normal coronary arteries, in whom a greater degree
of coronary vasoconstriction is likely needed to cause ischemia in the ab-
sence of critical coronary stenoses.
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Reduced Complexity of R-R Interval Dynamics in
Patients with Coronary Artery Disease
Helkki V Huikuri, Vesa Jokinen, Tapio Seppanen, Matti Niemela, K.E.
Juhani Airaksinen, Markku K. Linnaluoto, Agustin Castellanos. Division of
Cardiology, Department of Medicine, University of Oulu, Ou!u, Finland; Miami University
Medical Center, Miami, Florida
In order to assess the fractal characteristics of R-R interval dynamics and
the applicability of fractal model in detecting abnormalities in heart period
variability (HPV), fractal, spectral and time domain measures of HPV were
compared between 40 patients with uncomplicated coronary artery disease
(CAD) and 40 age-matched healthy subjects without evidence of heart dis-
ease. Fractal dimension (D) was calculated with an epsilon-blanket method
and autoregressive model was used in spectral analysis of HP\I. A good fit
of the regression line and a stable D (correlation coefficients >0.95) were
observed from the time epochs varying from 100 to 4 000 consecutive R-R
intervals. Patients with CAD had significantly lower 24-hour average D (1.66
± 0.09) compared to healthy subjects (1.74 ± 0.05) (p < 0.001 between the
groupsl, but none of the time or frequency domain measures of HPV, such
as standard deviation of R-R intervals, high-frequency, low-frequency or very
low-frequency power spectral components, differed significantly between
the groups.
R-R interval dynamics has fractal characteristics as evidenced by self-
similarity of D over wide range of R-R interval time series. Patients with CAD
have reduced dimensional complexity of R-R interval dynamics but no sig-
nificant alterations in specific autonomic or other regulatory systems that
modulate the periodic HR\I.
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1749-61 Arrhythmic and Nonarrhythmic Mortality Following
Acute Myocardial Infarction: Impact of Heart Rate
Variability and Left Ventricular Systolic Function
Juha Hartikainen, Anne Staunton, Jan Poloniecki, John Camm, Marek Malik. St
George's Hospital, Medical School, London, UK
Low heart rate variability has been found to be associated with increased risk
of malignant arrhythmias and sudden cardiac death after myocardial infarc-
tion (MI). Also impaired cardiac systolic function after MI predicts increased
mortality, which can be due to arrhythmias or progressive heart failure. We
studied the impact of heart rate variability and left ventricular ejection frac-
tion (LVEF) on arrhythmic (AM) and nonarrhythmic mortality(NAM) in patients
with acute MI. Arrhythmic death was defined as sudden death or unwit-
nessed death in patients with symptomatic sustained ventricular tachycardia
during the 2-year follow-up. Heart rate variability index (HRVI) and LVEF were
assessed before hospital discharge in 575 patients with acute MI. Patients
were divided into tertiles according to HRVI and LVEF. During a follow-up of
2 years, the average cardiac mortality (CM). AM and NAM were 8.2%, 5.0%
and 3.2%, respectively. When the whole patient population is concerned,
both low HRVI and LVEF were associated with increased risk of CM (p <
0.001), AM Ip < 0.001) and NAM (p < 0.001). When both risk factors were
present (patients with LVEF =" 40% and lowest HRVI tertile or HRVI =" 20
units and lowest LVEF tertii e) CM were highest (23.9% and 26.7%) and were
arrhythmic in 53% and 60% of cases, respectively. Patients with low HRVI as
the only risk factor (normal LVEF and lowest HRVI tertile) had CM of 15.5%
and in 70% it was due to AM. On the other hand, when LVEF was the only
risk factor (normal HRVI and lowest LVEF tertii e) CM was low (6.2%) and the
mechanism of death was nonarrhythmic in 71 %.
Conclusion: Our findings suggest that in the presence of low HRVI in-
creased mortality tends to be related to AM independently of LVEF, whereas
low LVEF predicts NAM, but only in the absence of HRVI risk factor.
New Insight Into Lipoprotein Abnormalities
and Disease
Tuesday, March 21,1995,10:30 a.m.-Noon
Ernest N. Morial Convention Center, Room 64
10:30
1750-1 1 Oxidized Low Density Lipoprotein Induced Activation
of Smooth Muscle Cell DNA Synthesis is Mediated
Through Active Oxygen Species and Lysolecithin
Ann Stika, Jan Regnstrom, Bojan Cercek, Prediman K. Shah, Jan Nilsson.
Cedars-Sinai Medical Center, Los Angeles, CA; Karolinska Institute, Stockholm, Sweden
It has been shown that oxidized low density lipoprotein (ox-LDL) stimulates
JACC February 1995
DNA synthesis in smooth muscle cells (SMC). Due to its complex chemical
structure it has been difficult to identify the active mitogenic components
of ox-LDL. Within the first 48 hours of oxidation we found a 75% reduction
of lecithin while lysolecithin was increased 25-fold, lipid peroxide levels in-
creased 8-fold and aldehydes increased 20-fold as determined by the thiobar-
bituric reactive (TBAR) assay. To identify the components of ox-LDL respon-
sible for stimulation of DNA synthesis, human arterial SMC were exposed
to various peroxides, aldehydes, and phospholipids and DNA synthesis was
analyzed by autoradiography using radioactive thymidine in corporation in
nuclei.
Substance % labelled nuclei ± SD p vs Ctl
Control (1% serum) 23.3 3.5
LDL 5/lg/ml 31.0 5.5 NS
ox-LDL 5 /lg/ml 75.Z 78 0.005
lysolecithin 10 /lM 75.3 45 0.003
LDL 5 /lg/ml + PhosholipaseAZ 41 U/ml 730 3.6 00001
HZOZ ZOO /lM 39.0 1.7 0.01
The DNA synthesis increased 3 fold with ox-LDL and this effect was repli-
cated by substituting lysolecithin or LDL + Phospholipase Az (to gener-
ate lysolecithin) for ox-LDL. Peroxides also had a modest stimulatory ef-
fect. Malondialdehyde, oxysterols, Iysophosphatidylserine, phosphatidylser-
ine, lecithin, sphingomyelin and sphingosine were without effect. Conclu-
sion: The present results indicate that the growth stimulatory effect of ox-
LDL is due to the formation of lysolecithin and peroxides during the oxidation
process.
10:45
Eicosapentaenoic Acid and Docosahexaenoic Acid in
Fish Oils Reverse the Thromboxane Az Induced
Vascular Smooth Muscle Cell Proliferation
Rajbabu Pakala, Rajashree Pakala, Claude R. Benedict. University of Texas Medical
School, Houston, Texas
There is conflicting data to indicate whether omega-3 fatty acids present in
dietary fish oil supplementation can prevent the development of restenosis
following angioplasty. Thromboxane Az (TxAz) released at sites of vascular
injury due to platelet aggregation, is a known mitogen for vascular smooth
muscle cells (SMC). This may playa role in the development of resteno-
sis follOWing angioplasty. We examined whether the omega-3 fatty acids,
eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) present in fish
oils, can prevent TxAz induced SMC proliferation. Canine primary aortic SMC
were grown in 1% fetal bovine serum with different concentrations of TxAz(U46619) and with 3.3 /lM each of EPA, DHA, linolenic acid (LOA) (n-3), oleic
acid (OA) (n-9) or without any fatty acids (control I. and then 3H-thymidine in-
corporated into the DNA of SMC was measured. We used LOA and OA as
non omega-3 unsaturated fatty acids for comparison in our study.
The data shows that the TxAz induced SMC proliferation is reversed by
EPA and DHA and not by LOA or OA.
Conclusion: This suggests that omega-3 fatty acids, EPA and DHA, may
attenuate the development of restenosis following coronary angioplasty by
inhibiting the TxAz induced SMC proliferation.
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The Role of Triglyceride-Rich Lipoprotein Families in
the Progression of Coronary Artery Atherosclerotic
Lesions
Howard N. Hodis, Wendy J. Mack, Carolyn Knight-Gibson, Petar Alaupovic.
University ofSouthern California, Los Angeles, CA; Oklahoma Medical Research
Foundation, Oklahoma City, OK
The affect of triglyceride-rich lipoprotein particles on the progression of coro-
nary artery atherosclerotic lesions is not known. In a subset of 270 subjects
in the Monitored Atherosclerosis Regression Study, lovastatin significantly
reduced apolipoprotein (Apo) B and cholesterol-rich lipoprotein (Lp) B levels
without significantly affecting triglyceride-rich Lp (LpBc) particles, Lp-B:C,
Lp-B:C:E, and Lp-AII:B:C:D:E. This differential affect of lovastatin on apoB-
containing lipoproteins offered the opportunity to determine the indepen-
dent relationship of LpB and specific LpBc particles on the progression of
coronary artery disease. Subjects were randomized to lovastatin 40 mg b.i.d.
or placebo for 2 years and progression determined by quantitative coronary
angiography. There were 15 progressors (P) and 15 nonprogressors (NP) in
the lovastatin group and 13 P and 13 NP in the placebo group. In the placebo
group, there was a significant difference between Pand NP (mean ± SEM) in
plasma triglyceride (259 ± 33.6 vs 142.9 ± 20.8, P = 0.003), apoCIII(16.1 ±
1.2 vs 11.9 ± 0.7, P = 0.021. and apoB (127.4 ± 5.9 vs 112.4 ± 4.7, P = 0.04)
levels. In the lovastatin group, there was a significant difference between P
and NP in Lp-AII:B:C:D:E (8.4 ± 1.3 vs 5.0 ± 0.9, p = 0.02) and apoAI (119.3 ±
61 vs 134.0 ± 3.6, p = 0.021 levels. However. there was no significant differ-
ence in Lp-B:C or Lp-B:C:E levels between P and NP. These data confirm the
atherogenic potential of LpB particles and show that after reduction of LpB
particles to below 75 mg/dL in the lovastatin group. LpBc particles in gen-
eral, and Lp-AII:B:C:D:E specifically, play an important role in progression of
coronary artery disease. The possible reason for the atherogenic potential
of Lp-AII: B:C: D: E relative to other LpBc particles may be related to its lower
reactivity toward lipoprotein lipase and therefore. longer residence time in
the circulation.
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1750-41 The Influence of Lipoprotein(a) Levels on the
Angiograpic Course of Coronary Atherosclerosis in
Patients with High and Low LDL·C
Jeroen Vos, Gilbert R. Thompson I, Pim J. de Feyter, Geert Boerma, Jean
M. Dumont, MMS Investigators. Thoraxcenter. Erasmus University Rotterdam, NL;
1 Hammersmith Hospital, London. UK
Introduction: Previous reports have indicated that a high level of Lp(a) is an
independent risk factor for coronary artery disease. Data from angiographic
regression trials suggest that the adverse effect of high Lp(a) can be amelio-
rated by lowering LDL-C.
Methods: Patients with mild coronary atherosclerosis and with total
cholesterol of 6.43 ± 0.75 mmolll, LDL-C 4.40 ± 0.69 mmolll, and LP(a)
25.4 ± 27.6 mgldl were treated with placebo (N = 167) or simvastatin 20
mg daily (N = 178). Quantitative Coronary Angiography was performed at
oand 4 years. Both the changes in mean lumen diameter (diffuse coronary
atherosclerosisI. and minimum lumen diameter and diameter stenosis (focal
coronary atherosclerosis) were assessed. Angiographic changes were strat-
ified by Lp(allevel and by LDL-C level during the trial.
Results: Simvastatin lowered TC by 23%, LDL-C by 31 %, Lp(a) was not
influenced. The angiographic changes over 4 years were as follows:
LDL-C < 3.5 >3.5 mmol/l P
Mininum Diameter (mm):
Lp(a) <35 mg/dl -0.05 ± 0.Z4 -0.15 ± 027 0.005
2::35 mg/dl -001 ± 0.Z4 -0.05 ± 0.Z5 ns
Diameter stenosis (%):
Lp(a) <35 mg/dl 0.5 ± 78 4.1 ± 95 0001
2::35 mg/dl 0.5 ± 67 Z.8 ± 7.9 ns
Mean Lumen Diameter (mm):
Lp(a) <35 mg/dl -0.05 ± OZ4 -0.09 ± 024 ns
>35 mg/dl 0.01 ± OZ5 -0.01 ± 0.Z4 ns
Conclusions: our findings contrast with previous reports and show that
high Lp(a) is associated with more progression of focal atherosclerosis (but
not diffuse) when LDL-C is low. Lowering LDL-C was more beneficial when
Lp(a) was low.
